
This interview with Christopher Sayed, MD, features a discussion about his team’s recent findings on bimekizumab for hidradenitis suppurativa.
Christopher J. Sayed, MD, is a professor of dermatology at the University of North Carolina School of Medicine. He is also the director of its HS clinic.

This interview with Christopher Sayed, MD, features a discussion about his team’s recent findings on bimekizumab for hidradenitis suppurativa.